ERTAPENEM SODIUM INJECTION

The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, a delivery order under contract SPE2DX25D9822 for the supply of ERTAPENEM SODIUM INJECTION (NSN 6505015035374) at a total price of $20.10, with an award date of July 20, 2026. The contract is a single-line-item award with no option quantities or variance allowed, specifying delivery of one package to the USS CHARLESTON LCS 18, located at FPO AP 96694, under FOB Destination terms, meaning the contractor bears all transportation costs and risks until delivery. The shipment must be sent via the fastest traceable means, and parcel post is strictly prohibited, with mandatory use of the Transportation Control Number R201566179M279 for tracking. The item is to be packaged and labeled with the CAGE codes 4PX51, 52SV1, and 99DM5, along with the NDC number 60505-6196-04 and NSN 6505015035374, though no explicit compliance with MIL-STD packaging or marking standards is detailed. Inspection and acceptance occur at the destination, and the contractor is responsible for all logistics under these terms. No formal FAR clauses, evaluation factors, or socioeconomic certifications are explicitly documented, and while administrative details such as the PR number 7017560994 and agency code 97AS are present, payment office, COR/COTR, or accounting data like TAS or AAC are not provided. The award is linked to prior procurement under SPE2DX-25-D-9822, indicating adherence to established medical supply protocols, and the use of DLA’s internal systems like VSM and DLAD implies integration with defense logistics frameworks, though invoicing procedures and electronic submission requirements remain unspecified.